Impact of volume control on left ventricular hypertrophy in dialysis patients

Journal of Nephrology

Volumn 15, Issue 6, 2002, Pages 655-660

  Özkahya, Mehmet ^a   Toz, Huseyin ^a   Özerkan, Filiz ^a   Duman, Soner ^a   Ok, Ercan ^a   Basci, Ali ^a   Mees, Evert J Dorhout ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Echocardiography; Hemodialysis; Hypertension; Left ventricular hypertrophy

Indexed keywords

SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY WEIGHT; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; KIDNEY FAILURE; MALE; MORTALITY; PREDICTION; PROSPECTIVE STUDY; SODIUM RESTRICTION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; WEIGHT GAIN;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE DETERMINATION; BODY WEIGHT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIET, SODIUM-RESTRICTED; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0036867351     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 (suppl 12): S16-23.
2. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-90.
3. Foley RN, Parfrey PS, Harnet JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-85.
4. Cannella G, Paoletti E, Delfino R, Peloso G, Molinari S, Traverso GB. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44: 881-6.
5. Foley RN, Parfrey PS, Harnet JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-92.
6. Harnet JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4: 1486-90.
7. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001; 38: 371-6.
8. Ozkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ. Regression of left ventricular hypertrophy in hemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998; 13: 1489-93.
9. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-8.
10. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 1987; 59: 956-60.
11. Ozkahya M, Toz H, Unsal A, Ozerkan F, Asci G, Gurgun C, Akcicek F, Mees EJ. Treatment of hypertension in dialysis patients by ultrafiltration: Role of cardiac dilatation and time factor. Am J Kidney Dis 1999; 34: 218-21.
12. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 1993; 65: 212-4.
13. Stewart GA, Foster J, Cowan M, Rooney E, McDonough T, Dargie HJ, Rodger RS, Jardine AG. Echocardiography over-estimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 1999; 56: 2248-53.
14. Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol 2000; 20: 396-401.
15. London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B. Cardiac hypertrophy and arterial alterations in end-stage renal disease: Hemodynamic factors. Kidney Int 1993; 41 (suppl 41): S42-9.
16. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58: 1325-35.
17. Jeren-Strujic B, Raos V, Jeren T, Horvatin-Godler S. Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO). Angiology 2000; 51: 131-9.
18. Huting J, Kramer W, Schutterle G, Wizemann V. Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. Nephron 1988; 49: 284-90.
19. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic over activity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-8.
20. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998; 54: 561-9.
21. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507-17.
22. Eichna L.W. Circulation congestion and heart failure. Circulation 1960; 22: 864-5.
23. Chazot C, Charra B, Vo Van C, Jean G, Vanel T, Calemard E, Terrat JC, Ruffet M, Laurent G. The Janus-faced aspect of 'dry weight'. Nephrol Dial Transplant 1999; 14: 121-4.
24. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: Importance of the lag phenomenon. Am J Kidney Dis 1998; 32: 720-4.